Verified stock metrics

Scribe Therapeutics Key Stock Metrics

Direct answer

Scribe Therapeutics has 7 verified key metrics available.

Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked November 19, 2026.

Get free Scribe Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Market capitalization
$250.35M
Price-to-book ratio
2x
Dividend yield
0%
52-week price range
$12.58 to $39.60
Revenue growth
-91.9%
Profit margin
-294.35%
Debt-to-equity ratio
4.11%